MedPath
FDA Approval

PHENDIMETRAZINE TARTRATE

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
November 19, 2019
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Phendimetrazine(35 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

CALVIN, SCOTT AND COMPANY, INCORPORATED

CALVIN, SCOTT AND COMPANY, INCORPORATED

073404626

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

PHENDIMETRAZINE TARTRATE

Product Details

NDC Product Code
17224-501
Application Number
ANDA085588
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 9, 2019
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
Code: 6985IP0T80Class: ACTIBQuantity: 35 mg in 1 1
FD&C YELLOW NO. 5Inactive
Code: I753WB2F1MClass: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94EClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65APClass: IACT
SUCROSEInactive
Code: C151H8M554Class: IACT
© Copyright 2025. All Rights Reserved by MedPath